A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

GLP-1 agonists like Ozempic effectively help manage obesity, but quitting the medication can lead to a resurgence in weight ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

Ozempic has FDA approval to treat type 2 diabetes. Wegovy has approval to help people lose weight when they have both obesity and weight-related health problems. Ozempic and Wegovy are part of a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Proponents say long-term savings could outweigh the cost — especially in West Virginia, which has the nation's highest rates ...

I attended my high school reunion and had no anxiety about appearance,” Sarah gushed. “My new problem was graciously ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases remain rare. Here's what experts want you to know.